The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target.

The list of cell surface receptors crosslinking with the c-MET signaling is constantly growing, highlighting the importance of this pathway for personalized target therapy. Research on the combination of c-MET inhibitors with other drugs will hopefully lead to discovery of new effective treatment options.